Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Transmission Electron Microscope

By Drug Discovery Trends Editor | July 18, 2008

FEI Company offers a high-throughput, cryo transmission electron microscope (TEM) that combines high-throughput sample handling with state-of-the-art electron optics.  It provides fully-automated three-dimensional data about biological molecules and macromolecular complexes.  Designed specifically for the needs of cellular and structural biologists, the all-new Titan Krios TEM enables visualization of intricate interactive mechanisms of individual proteins and molecular machines within the three-dimensional architecture of living cells.

The Titan Krios is ideal for advanced, high-resolution, dual-axis cryo electron tomography of frozen hydrated cells and cell organelles, single particle analysis and 2D electron crystallography.  Based on FEI’s industry-leading Titan platform, the Titan Krios delivers superb stability and imaging with the flexibility of selecting optimum acceleration voltages between 80 and 300 kV.  The Titan Krios also features robotic, contamination-free “auto-loading” of up to 12 frozen samples and 24×7 operation due to liquid nitrogen auto fill systems. Finally, its environmental instrument enclosure provides optimal thermal and acoustic shielding reducing installation and operating requirements.

FEI Company 


Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE